201 related articles for article (PubMed ID: 10593363)
41. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
[TBL] [Abstract][Full Text] [Related]
42. Dienogest reduces HSD17β1 expression and activity in endometriosis.
Mori T; Ito F; Matsushima H; Takaoka O; Koshiba A; Tanaka Y; Kusuki I; Kitawaki J
J Endocrinol; 2015 May; 225(2):69-76. PubMed ID: 25767055
[TBL] [Abstract][Full Text] [Related]
43. Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism.
Murakami K; Nomura K; Shinohara K; Kasai T; Shozu M; Inoue M
Fertil Steril; 2006 Aug; 86(2):291-7. PubMed ID: 16806212
[TBL] [Abstract][Full Text] [Related]
44. [Perspectives on endometriosis: new physiopathologic approaches and treatments].
Vigano P;
J Gynecol Obstet Biol Reprod (Paris); 2003 Dec; 32(8 Pt 2):S28-31. PubMed ID: 14968065
[TBL] [Abstract][Full Text] [Related]
45. Peroxisome proliferator-activated receptor gamma, coactivator 1α enhances local estrogen biosynthesis by stimulating aromatase activity in endometriosis.
Suganuma I; Mori T; Ito F; Tanaka Y; Sasaki A; Matsuo S; Kusuki I; Kitawaki J
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1191-8. PubMed ID: 24654751
[TBL] [Abstract][Full Text] [Related]
46. [Semiquantitative analysis of mRNA aromatase expression in eutopic endometrium as a diagnostic marker of endometriosis and estrogen dependent diseases].
Visnovský J; Galo S; Zúbor P; Hatok J; Racay P; Danko J
Ceska Gynekol; 2008 Jul; 73(4):213-7. PubMed ID: 18711959
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy.
Purohit A; Fusi L; Brosens J; Woo LW; Potter BV; Reed MJ
Hum Reprod; 2008 Feb; 23(2):290-7. PubMed ID: 18056119
[TBL] [Abstract][Full Text] [Related]
48. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells.
Izawa M; Harada T; Taniguchi F; Ohama Y; Takenaka Y; Terakawa N
Fertil Steril; 2008 May; 89(5 Suppl):1390-6. PubMed ID: 17662285
[TBL] [Abstract][Full Text] [Related]
49. [Inhibitory effect on estrogen production and its influence on invasive ability of human endometrial cells of endometriosis by medicated serum of SLW].
Li A; Wang Y; Dong W; Xu X
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(12):1607-11. PubMed ID: 20815218
[TBL] [Abstract][Full Text] [Related]
50. Absence of aromatase protein and mRNA expression in endometriosis.
Colette S; Lousse JC; Defrère S; Curaba M; Heilier JF; Van Langendonckt A; Mestdagt M; Foidart JM; Loumaye E; Donnez J
Hum Reprod; 2009 Sep; 24(9):2133-41. PubMed ID: 19493871
[TBL] [Abstract][Full Text] [Related]
51. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis.
Maia H; Haddad C; Coelho G; Casoy J
Womens Health (Lond); 2012 Nov; 8(6):647-58. PubMed ID: 23181530
[TBL] [Abstract][Full Text] [Related]
52. [Study on inhibitory effect of medicated serum of SLW on estrogen production by human endometrial cells of endometriosis].
Li A; Xu XY; Wang H; Chen G
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(6):686-90. PubMed ID: 18590202
[TBL] [Abstract][Full Text] [Related]
53. 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis.
Bulun SE; Cheng YH; Pavone ME; Yin P; Imir G; Utsunomiya H; Thung S; Xue Q; Marsh EE; Tokunaga H; Ishikawa H; Kurita T; Su EJ
Semin Reprod Med; 2010 Jan; 28(1):44-50. PubMed ID: 20108182
[TBL] [Abstract][Full Text] [Related]
54. Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells.
Qi Q; Liu X; Zhang Q; Guo SW
Sci Rep; 2020 Jan; 10(1):1281. PubMed ID: 31992765
[TBL] [Abstract][Full Text] [Related]
55. PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling.
Lebovic DI; Kavoussi SK; Lee J; Banu SK; Arosh JA
Endocrinology; 2013 Dec; 154(12):4803-13. PubMed ID: 24064359
[TBL] [Abstract][Full Text] [Related]
56. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
57. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
[TBL] [Abstract][Full Text] [Related]
58. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium.
Kitawaki J; Noguchi T; Amatsu T; Maeda K; Tsukamoto K; Yamamoto T; Fushiki S; Osawa Y; Honjo H
Biol Reprod; 1997 Sep; 57(3):514-9. PubMed ID: 9282984
[TBL] [Abstract][Full Text] [Related]
59. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism.
Cheng YH; Imir A; Fenkci V; Yilmaz MB; Bulun SE
Am J Obstet Gynecol; 2007 Apr; 196(4):391.e1-7; discussion 391.e7-8. PubMed ID: 17403431
[TBL] [Abstract][Full Text] [Related]
60. Evidence for estrogen synthesis in adenomyotic tissues.
Yamamoto T; Noguchi T; Tamura T; Kitawaki J; Okada H
Am J Obstet Gynecol; 1993 Sep; 169(3):734-8. PubMed ID: 8372890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
